JP2001510154A5 - - Google Patents

Download PDF

Info

Publication number
JP2001510154A5
JP2001510154A5 JP2000502767A JP2000502767A JP2001510154A5 JP 2001510154 A5 JP2001510154 A5 JP 2001510154A5 JP 2000502767 A JP2000502767 A JP 2000502767A JP 2000502767 A JP2000502767 A JP 2000502767A JP 2001510154 A5 JP2001510154 A5 JP 2001510154A5
Authority
JP
Japan
Prior art keywords
methyl
ethyl
acetamide
pyrrolidinyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000502767A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001510154A (ja
Filing date
Publication date
Priority claimed from US08/891,833 external-priority patent/US5763445A/en
Application filed filed Critical
Publication of JP2001510154A publication Critical patent/JP2001510154A/ja
Publication of JP2001510154A5 publication Critical patent/JP2001510154A5/ja
Pending legal-status Critical Current

Links

JP2000502767A 1997-07-14 1998-06-19 カッパアゴニスト化合物、製剤、ならびにそれらによる掻痒の予防法および治療法 Pending JP2001510154A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/891,833 1997-07-14
US08/891,833 US5763445A (en) 1996-03-08 1997-07-14 Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
PCT/US1998/012769 WO1999003468A1 (en) 1997-07-14 1998-06-19 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith

Publications (2)

Publication Number Publication Date
JP2001510154A JP2001510154A (ja) 2001-07-31
JP2001510154A5 true JP2001510154A5 (https=) 2006-01-05

Family

ID=25398903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000502767A Pending JP2001510154A (ja) 1997-07-14 1998-06-19 カッパアゴニスト化合物、製剤、ならびにそれらによる掻痒の予防法および治療法

Country Status (12)

Country Link
US (7) US5763445A (https=)
EP (1) EP0998281A1 (https=)
JP (1) JP2001510154A (https=)
KR (1) KR20010021853A (https=)
AU (1) AU725232B2 (https=)
BR (1) BR9810712A (https=)
CA (1) CA2289055A1 (https=)
IL (1) IL132388A0 (https=)
NO (2) NO996352L (https=)
NZ (2) NZ500439A (https=)
WO (1) WO1999003468A1 (https=)
ZA (1) ZA986208B (https=)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6303611B1 (en) * 1996-03-08 2001-10-16 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US6750216B2 (en) * 1996-03-08 2004-06-15 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5763445A (en) * 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
MXPA99011298A (es) * 1997-07-14 2004-10-28 Adolor Corp Formulaciones farmaceuticas antiprurito de agonista kappa y metodo para tratar prurito con las mismas.
WO1999032096A1 (en) * 1997-12-22 1999-07-01 Alza Corporation Novel formulations for the transdermal administration of asimadoline
CA2326777C (en) 1998-04-01 2011-12-20 Nortran Pharmaceuticals Inc. Aminocyclohexyl ether compounds and uses thereof
US6548637B1 (en) 1998-06-18 2003-04-15 Sepracor, Inc. Ligands for opioid receptors
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6383511B1 (en) 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
WO2001036006A1 (en) * 1999-11-19 2001-05-25 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
US7115664B2 (en) * 2000-03-16 2006-10-03 Sepracor Inc. Peptidomimetic ligands for cellular receptors and ion channels
WO2002007682A1 (en) * 2000-07-26 2002-01-31 Vyden John K Methods for treating atopic disorders
AR030128A1 (es) * 2000-08-08 2003-08-13 Daiichi Seiyaku Co Una preparacion solida altamente absorbible
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7181547B1 (en) 2001-06-28 2007-02-20 Fortinet, Inc. Identifying nodes in a ring network
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7732451B2 (en) 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
CA2462200A1 (en) * 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7655658B2 (en) * 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
DE10252666A1 (de) * 2002-11-11 2004-08-05 Grünenthal GmbH N-Piperidyl-cyclohexan-Derivate
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7968548B2 (en) * 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
US7345086B2 (en) 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
CA2524323C (en) 2003-05-02 2012-05-15 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
WO2005018635A2 (en) 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
MXPA06011419A (es) 2004-04-01 2007-04-20 Cardiome Pharma Corp Profarmacos de compuestos moduladores de canales ionicos y usos de los mismos.
WO2005097087A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
ES2483940T3 (es) 2004-11-08 2014-08-08 Cardiome Pharma Corp. Un nuevo régimen de dosificación para compuestos moduladores del canal iónico para el tratamiento de la fibrilación auricular aguda en un ser humano
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
DE102007062550A1 (de) * 2007-12-20 2009-06-25 Westfälische Wilhelms-Universität Münster Körperschaft des öffentlichen Rechts Perhydrochinoxalin-Derivate
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
KR20160008237A (ko) * 2013-05-17 2016-01-21 독토르. 아우구스트 볼프 게엠베하 운트 코. 카게 아르쯔네이미텔 진통제로서 유용한 퍼하이드로퀴녹살린 유도체
US8906951B1 (en) 2013-06-24 2014-12-09 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
US9198898B2 (en) 2013-06-24 2015-12-01 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
JP6369783B2 (ja) * 2014-06-12 2018-08-08 株式会社アーダン 加水分解フィブロインを含む軟膏及びその製造方法
EP3829574A1 (en) * 2018-07-27 2021-06-09 Vyne Therapeutics Inc. Use of neurokinin-1 antagonists to treat pruritus
EP3932390A1 (en) * 2020-07-02 2022-01-05 Dr. August Wolff GmbH & Co. KG Arzneimittel Topical gel formulation containing asimadoline

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065573A (en) * 1976-06-03 1977-12-27 The Upjohn Company 4-Amino-4-phenylcyclohexanone ketal compositions and process of use
US4098904A (en) * 1976-11-12 1978-07-04 The Upjohn Company Analgesic n-(2-aminocycloaliphatic)benzamides
US4145435A (en) * 1976-11-12 1979-03-20 The Upjohn Company 2-aminocycloaliphatic amide compounds
US4212878A (en) * 1978-01-26 1980-07-15 The Upjohn Company Phenylacetamide derivative analgesics
DE3003303C2 (de) 1980-01-30 1984-03-08 Siemens AG, 1000 Berlin und 8000 München Verfahren zur Mattierung von hochglänzenden Epoxidharzoberflächen bei Leiterplatten
US4466977A (en) * 1981-04-09 1984-08-21 The Upjohn Company N-[2-Amino(oxy- or thia- group-substituted-cycloaliphatic)]benzeneacetamides and -benzamide analgesics
US4359476A (en) * 1981-04-09 1982-11-16 The Upjohn Company Adjacently substituted cycloalkane-amide analgesics
US4360531A (en) * 1981-04-09 1982-11-23 The Upjohn Company Substituted cycloalkanes
US4438130A (en) * 1981-11-12 1984-03-20 The Upjohn Company Analgesic 1-oxa-, aza- and thia-spirocyclic compounds
US4463013A (en) * 1982-04-09 1984-07-31 The Upjohn Company Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as water diuretic drugs
US4656182A (en) * 1983-12-06 1987-04-07 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
US4737493A (en) * 1985-07-01 1988-04-12 Warner-Lambert Company 7-((substituted)amino)-8-((substituted)carbonyl)-methylamino)-1-oxaspiro(4,5)decanes as analgesic agents
US4663343A (en) * 1985-07-19 1987-05-05 Warner-Lambert Company Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds
FR2592879B1 (fr) * 1986-01-13 1988-04-29 Roussel Uclaf Nouveaux derives de la decahydroquinoleine, leur procede de preparation, les intermediaires de preparation, leur application a titre de medicaments et les compositions les renfermant
GB8618188D0 (en) 1986-07-25 1986-09-03 Ici Plc Diamine compounds
ZA876778B (en) 1986-09-10 1989-05-30 Du Pont Benzo-fused cycloalkane and oxa-and thia-,cycloalkane trans-1,2-diamine derivatives
US4876269A (en) 1986-09-10 1989-10-24 E. I. Du Pont De Nemours And Company Benoz-fused cycloalkane trans-1,2-diamine derivatives
DE3766335D1 (de) 1986-09-17 1991-01-03 Zambeletti Spa L N-1-acylierte-(1-(phenyl- oder benzyl-))-1,2-aethylendiamine.
GB8801304D0 (en) 1988-01-21 1988-02-17 Ici Plc Diamine compounds
FR2627491B1 (fr) 1988-02-18 1992-01-24 Roussel Uclaf Nouveaux derives du benzocyclohexane et du benzocycloheptane ainsi que leurs sels, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
US4855316A (en) * 1988-02-18 1989-08-08 Warner-Lambert Company 1,2-diamino-4,5-dimethoxycyclohexyl amide analgesic compounds
GB8804014D0 (en) 1988-02-23 1988-03-23 Humphreys & Glasgow Ltd Synthesis gas production
GB8804104D0 (en) * 1988-02-23 1988-03-23 Glaxo Group Ltd Chemical compounds
EP0330467A1 (en) * 1988-02-23 1989-08-30 Glaxo Group Limited Heterocyclic compounds
KR890012970A (ko) 1988-02-23 1989-09-20 추후보충 테트라히드로 이소퀴놀린 유도체
CA1336909C (en) 1988-03-16 1995-09-05 Vittorio Vecchietti Heterocyclic derivatives
PT90619B (pt) 1988-05-23 1994-10-31 Glaxo Group Ltd Processo para a preparacao de compostos de piperazina
US5021413B1 (en) 1988-08-24 1994-12-13 Sankyo Co Analgesic thiomorpholins, their preparation, and pharmaceutical compositions containing them
GB8824400D0 (en) * 1988-10-18 1988-11-23 Glaxo Group Ltd Chemical compounds
AU626949B2 (en) * 1988-12-06 1992-08-13 Warner-Lambert Company 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
DK626889A (da) 1988-12-16 1990-06-17 Roussel Uclaf Indanderivater, deres fremstilling samt laegemidler med indhold deraf
GB8830219D0 (en) 1988-12-23 1989-02-22 Zambeletti Spa L Novel compounds
US5232978A (en) 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
DE4034785A1 (de) 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US4906655A (en) * 1989-01-24 1990-03-06 Warner-Lambert Company Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents
US4965278A (en) 1989-04-21 1990-10-23 Warner-Lambert Company 7-(substituted)amino)-8-((substituted)carbonyl)-methylamino)-1-oxaspiro[4,5]decanes as diuretics antiiflammatory, and cerebrovascular agents
EP0398720A3 (en) 1989-05-18 1991-07-03 Glaxo Group Limited Piperazine derivatives
GB8916395D0 (en) 1989-07-18 1989-09-06 Zambeletti Spa L Pharmaceuticals
EP0585296A1 (en) * 1991-05-21 1994-03-09 Smithkline Beecham Farmaceutici S.p.A. 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists
KR970011390B1 (ko) 1992-01-23 1997-07-10 도레이 가부시키가이샤 모르피난 유도체와 약리학적으로 허용되는 이의 산 부가염 및 이를 함유하는 약제학적 조성물
DE4215213A1 (de) 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide
US5475019A (en) 1993-02-08 1995-12-12 East Carolina University Method of treating anxiety-related disorders with 2-aminocycloaliphatic amide compounds
WO1994018165A1 (en) 1993-02-12 1994-08-18 Pfizer Inc. Sulfonamide compounds as opioid k-receptor agonists
AU686203B2 (en) 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use
WO1996006078A1 (en) 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists
US5610271A (en) 1995-06-07 1997-03-11 Torrey Pines Institute For Molecular Studies Kappa receptor selective opioid peptides
DE19523502A1 (de) 1995-06-28 1997-01-02 Merck Patent Gmbh Kappa-Opiatagonisten für entzündliche Darmerkrankungen
US5804595A (en) * 1995-12-05 1998-09-08 Regents Of The University Of Minnesota Kappa opioid receptor agonists
US6057323A (en) 1996-03-08 2000-05-02 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6239154B1 (en) * 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6303611B1 (en) 1996-03-08 2001-10-16 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5688955A (en) * 1996-03-08 1997-11-18 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
ES2236630T3 (es) * 1996-11-25 2005-07-16 Toray Industries, Inc. Agente antipruritico.
US5849762A (en) * 1997-07-14 1998-12-15 Adolor Corporation Peripherally acting anti-pruritic opiates
MXPA99011298A (es) * 1997-07-14 2004-10-28 Adolor Corp Formulaciones farmaceuticas antiprurito de agonista kappa y metodo para tratar prurito con las mismas.
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
EP1301213B1 (en) * 2000-07-21 2017-01-18 ReVance Therapeutics, Inc. Multi-component biological transport systems

Similar Documents

Publication Publication Date Title
JP2001510154A5 (https=)
JP2840448B2 (ja) インドール誘導体
CN1882587B (zh) 三环化合物作为甘氨酸转运抑制剂的用途
WO1994014770A1 (en) Tryptamine analogues as 5-ht1-like agonists
EP0912513A1 (en) Fibrinogen receptor antagonist prodrugs
NZ526893A (en) Isoindole-imide compounds, compositions, and uses thereof
JP2005519932A5 (https=)
JP2005511532A5 (https=)
JP2005509622A5 (https=)
JP2005505618A5 (https=)
PT1354884E (pt) Composto de ciclopenta (d) pirazolo [1,5-a] piramida como antagonista de receptor de crf
JP2010534218A (ja) 新規ブラジキニンｂ１アンタゴニスト
WO2004110995A1 (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
CN111875607A (zh) 手性吡咯并嘧啶化合物的制备方法
KR920701193A (ko) 신규 크로만 및 티오크로만 유도체
JPS6160657A (ja) エチレンジアミンモノアミド誘導体
JP6837072B2 (ja) ６，７−ジヒドロ−５Ｈ−ピラゾロ［５，１−ｂ］［１，３］オキサジン−２−カルボキサミド化合物
MXPA04002653A (es) Metodo para preparar compuestos de pirimidinona y sales farmaceuticamente aceptables del mismo.
Tang et al. Rhodium (III)-catalyzed C4-amidation of indole-oximes with dioxazolones via C–H activation
CZ20032677A3 (cs) Derivát fenylheterocyklyletheru jako inhibitor reabsorpce serotoninu, jeho použití a farmaceutický prostředek, který ho obsahuje
JPS58172379A (ja) 新規なキナゾリン誘導体
JP2005530809A (ja) フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用
JP2011500796A (ja) 新規前駆体
JPH0674264B2 (ja) １―（ピリジニルアミノ）―２―ピロリジノンおよびその製造法
ES2296177T3 (es) Procedimiento para preparar derivados de 2-oxo-1-pirrolidina por alilacion intramolecular.